相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autophagy-dependent glutaminolysis drives superior IL21 production in HIV-1-specific CD4 T cells
Hamza Loucif et al.
AUTOPHAGY (2022)
Lipophagy confers a key metabolic advantage that ensures protective CD8A T-cell responses against HIV-1
Hamza Loucif et al.
AUTOPHAGY (2021)
Impact of Integrase inhibitors and tenofovir alafenamide on weight gain in people with HIV
Jordan E. Lake et al.
CURRENT OPINION IN HIV AND AIDS (2021)
Alveolar macrophages from persons living with HIV show impaired epigenetic response to Mycobacterium tuberculosis
Wilian Correa-Macedo et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV
Willem D. F. Venter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Mitochondrial membrane potential
Ljubava D. Zorova et al.
ANALYTICAL BIOCHEMISTRY (2018)
HIV antiretroviral therapy drugs induce premature senescence and altered physiology in HUVECs
Justin Cohen et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2018)
Human Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune Response
Farhan Basit et al.
FRONTIERS IN IMMUNOLOGY (2018)
The spectrum of T cell metabolism in health and disease
Glenn R. Bantug et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Astrocyte Senescence and Metabolic Changes in Response to HIV Antiretroviral Therapy Drugs
Justin Cohen et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Tenofovir alafenamide (TAF) does not deplete mitochondrial DNA in human T-cell lines at intracellular concentrations exceeding clinically relevant drug exposures
Kirsten M. Stray et al.
ANTIVIRAL RESEARCH (2017)
Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection
Theodoros Kelesidis et al.
AIDS (2016)
A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results
David Wohl et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
Paul E. Sax et al.
LANCET (2015)
Sex differences in mitochondrial (dys)function: Implications for neuroprotection
Tyler G. Demarest et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2015)
Metabolism of stromal and immune cells in health and disease
Bart Ghesquiere et al.
NATURE (2014)
Relation of mitochondrial oxygen consumption in peripheral blood mononuclear cells to vascular function in type 2 diabetes mellitus
Mor-Li Hartman et al.
VASCULAR MEDICINE (2014)
A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes:, Implications for their use as bioenergetic biomarkers
Philip A. Kramer et al.
REDOX BIOLOGY (2014)
Methods for Assessing Mitochondrial Function in Diabetes
Christopher G. R. Perry et al.
DIABETES (2013)
Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults
Peter J. Ruane et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Role of Mitochondria in HIV Infection and Associated Metabolic Disorders: Focus on Nonalcoholic Fatty Liver Disease and Lipodystrophy Syndrome
P. Perez-Matute et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Clinical Use of HIV Integrase Inhibitors: A Systematic Review and Meta-Analysis
Peter Messiaen et al.
PLOS ONE (2013)
Mitochondrial DNA: a proinflammatory 'enemy from within' during HIV infection?
M. Pinti et al.
CELL DEATH & DISEASE (2012)
Assessing mitochondrial dysfunction in cells
Martin D. Brand et al.
BIOCHEMICAL JOURNAL (2011)
Mitochondrial complex I impairment in leukocytes from type 2 diabetic patients
Antonio Hernandez-Mijares et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Tenofovir renal toxicity targets mitochondria of renal proximal tubules
James J. Kohler et al.
LABORATORY INVESTIGATION (2009)
Mitochondrial DNA oxidation and manganese superoxide dismutase activity in peripheral blood mononuclear cells from type 2 diabetic patients
M. Garcia-Ramirez et al.
DIABETES & METABOLISM (2008)
Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes
KF Petersen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Mitochondrial toxicity of NRTI antiviral drugs: An integrated cellular perspective
W Lewis et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Bioenergetics of human peripheral blood mononuclear cell metabolism in quiescent, activated, and glucocorticoid-treated states
D Schmid et al.
BIOSCIENCE REPORTS (2000)
分享论文
